402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample

In this episode, Jim Otvos, Ph.D., recounts the unlikely story of transforming a flawed cancer test into a new way of measuring lipoproteins, explains what standard cholesterol tests can miss and why LDL-P and apoB can inform treatment decisions beyond LDL cholesterol alone, and dispels the misconception that large, “fluffy” LDL particles are benign. View show notes here: https://peterattiamd.com/jimotvos/ Become a member to receive exclusive content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ 0:00:00 - Intro 0:00:11 -